Dec 4, 2015· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2013-N-0502-0073
Please see the attached comments of the National Association of Chain Drug Stores in follow-up to the October 5-6, 2015 Public Meeting that FDA hosted on the impact of REMS on the healthcare delivery system, including the impact on patients and healthcare providers. These comments express support for FDA's recently announced REMS pilot program to standardize REMS information, as well as the agency's future plans to develop a Common REMS Platform. NACDS appreciates FDA considering our input on this topic.
Oct 28, 2015· Comment from Michelle Cope, National Association of Chain Drug Stores· FDA-2013-N-0502-0070
Please see the attached statement provided at the October 5, 2015 public meeting by Michelle Cope, Director, State Public Policy for the National Association of Chain Drug Stores (NACDS.) NACDS appreciates FDA considering our input on this topic.
Dec 3, 2014· Comment from the National Association of Chain Drug Stores· FDA-2013-N-0502-0052
See the attached comments of the National Association of Chain Drug Stores in response to the Food and Drug Administration (FDA) draft report on standardization of risk evaluation and mitigation strategies. We appreciate FDA considering our perspectives on this topic.
Sep 23, 2013· National Association of Chain Drug Stores - Comment· FDA-2013-N-0502-0019
Filed on regulations.gov — full text not in the inline record.